Nastoupil, Loretta J.; Hess, Georg; Pavlovsky, Miguel A. et al.
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphomaBLOOD ADVANCES. Bd. 7. H. 22. 2023 S. 7141-7150
Castven, Darko; Keggenhoff, Friederike; Stojkovic, Stojan et al.
Positive effects of PARP-1 inhibition in KRAS-mutated intrahepatic cholangiocarcinoma is mediated by CHK1 kinaseJOURNAL OF HEPATOLOGY. Bd. 78. 2023 S. S536-S537
Mai, Elias K.; Hielscher, Thomas; Bertsch, Uta et al.
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patientsLEUKEMIA. 2023
Gerbitz, Armin; Gary, Regina; Aigner, Michael et al.
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 studyFRONTIERS IN IMMUNOLOGY. Bd. 14. 2023
Bodmer, Nicole; Hecker-Nolting, Stefanie; Friedel, Godehard et al.
Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study GroupCANCER. 2023
Maier, Daniel; Vehreschild, Joerg Janne; Uhl, Barbara et al.
Profile of the multicenter cohort of the German Cancer Consortium's Clinical Communication PlatformEUROPEAN JOURNAL OF EPIDEMIOLOGY. 2023
Pielenhofer, Jonas; Meiser, Sophie Luise; Gogoll, Karsten et al.
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal ProductPHARMACEUTICS. Bd. 15. H. 2. 2023
Schlenk, R. F.; Weber, D.; Krzykalla, J. et al.
Randomized phase-III study of low-dose cytarabine and etoposide? plus ?/- all-<i>trans</i> retinoic acid in older unfit patients with <i>NPM1</i>-mutated acute myeloid leukemiaSCIENTIFIC REPORTS. Bd. 13. H. 1. 2023
Nowakowski, Grzegorz S.; Yoon, Dok Hyun; Mondello, Patrizia et al.
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphomaANNALS OF HEMATOLOGY. Bd. 102. H. 7. 2023 S. 1773-1787
Hess, Georg; Vucinic, Vladan; Rejeski, Kai et al.
Real World Results of Brexucabtagene Autoleucel for Patients with Relapsed/Refractory Mantle Cell Lymphoma - First German/Swiss AnalysisBLOOD. Bd. 142. 2023